Hip
Senior Member
- Messages
- 18,137
Though why do we not see any such rapid tolerance for other conditions for which Abilify is prescribed?
Yes, good question.
Pure speculation, but it could be along the lines that because ME/CFS patients have trouble acetylating (as the link posted by @wigglethemouse details), that throws out epigenetic regulation a bit. ME/CFS patients would be shifted towards histone deacetylation rather than histone acetylation.
Benzodiazepine tolerance — involving the down-regulation of GABA receptors caused by benzodiazepine use — is driven by histone deacetylation (removal of the acetyl molecule from histone), according to the paper I linked to above.
So if Abilify tolerance was similarly driven, you might expect tolerance to build up faster in ME/CFS patients compared to other people.